SCHEMBL31439643

SCHEMBL31439643

CCOC(=O)C(C(C)=O)C(=O)c1cccc(C(=O)OC)c1.[Cu+2]

nearest known ligand 0.48

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 1/20 0.48
LOXL2 Q9Y4K0 1/20 0.48
CYP4F2 P78329 3/20 0.47
CYP4A11 Q02928 3/20 0.47
CREBBP Q92793 1/20 0.44
KDM4E B2RXH2 2/20 0.43
NPSR1 Q6W5P4 1/20 0.43
ALDH1A1 P00352 3/20 0.42
MAPT P10636 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MEP1B Q16820 1/20 0.41
TSHR P16473 2/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1436172 0.99 SLC7A5 (0.49) SLC7A5LOXL2CYP4F2CYP4A11CREBBP
SCHEMBL3144570 0.84 TDP1 (0.49) LOXL2KDM4EALDH1A1MAPTRAB9A
SCHEMBL11166563 0.83 KDM4E (0.51) KDM4EALDH1A1MAPTKMT2A
SCHEMBL2036336 0.79 NPC1 (0.54) ALDH1A1MAPTRAB9ASMN1; SMN2TSHR
SCHEMBL5166543 0.79 CYP4F2 (0.58) LOXL2CYP4F2CYP4A11KDM4ENPSR1
SCHEMBL2846127 0.77 SLC7A5 (0.60) SLC7A5LOXL2CYP4F2CYP4A11KDM4E
SCHEMBL1436524 0.76 CA2 (0.43) KDM4ENPSR1ALDH1A1MAPTRAB9A
SCHEMBL11067487 0.75 SMN1; SMN2 (0.41) KDM4ENPSR1ALDH1A1MAPTRAB9A
SCHEMBL259243 0.75 LOXL2 (0.53) LOXL2CYP4F2CYP4A11CREBBPKDM4E
SCHEMBL28181740 0.74 MMP8 (0.50) SLC7A5LOXL2CYP4F2CYP4A11KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4747238-A1 PROCESS FOR PREPARING INTERMEDIATES OF SARTAN ACTIVE COMPOUNDS Sanofi (FR) 2026-05-27 EP claimed
WO-2025021696-A1 PROCESS FOR PREPARING INTERMEDIATES OF SARTAN ACTIVE COMPOUNDS SANOFI (FR) 2025-01-30 WO claimed
EP-4747238-A1 PROCESS FOR PREPARING INTERMEDIATES OF SARTAN ACTIVE COMPOUNDS Sanofi (FR) 2026-05-27 EP disclosed
WO-2025021696-A1 PROCESS FOR PREPARING INTERMEDIATES OF SARTAN ACTIVE COMPOUNDS SANOFI (FR) 2025-01-30 WO disclosed